Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial
- PMID: 24944404
- PMCID: PMC4053034
- DOI: 10.1016/j.curtheres.2003.08.006
Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial
Abstract
Background: (-)-Hydroxycitric acid (HCA) is an active ingredient extracted from the rind of the Indian fruit Garcinia cambogia. It inhibits adenosine triphosphate citrate lyase and has been used in the treatment of obesity.
Objective: The primary end point of this study was the effects of 12 weeks of G cambogia extract administration on visceral fat accumulation. The secondary end points were body indices (including height, body weight, body mass index [BMI], waist and hip circumference, and waist-hip ratio) and laboratory values (including total cholesterol, triacylglycerol, and free fatty acid).
Methods: This study was performed according to a double-blind, randomized, placebo-controlled, parallel-group design. Subjects aged 20 to 65 years with a visceral fat area >90 cm(2) were enrolled. Subjects were randomly assigned to receive treatment for 12 weeks with G cambogia (containing 1000 mg of HCA per day) or placebo. At the end of the treatment period, both groups were administered placebo for 4 weeks to assess any rebound effect. Each subject underwent a computed tomography scan at the umbilical level at -2, 0, 12, and 16 weeks.
Results: Forty-four subjects were randomized at baseline, and 39 completed the study (G cambogia group, n = 18; placebo group, n = 21). At 16 weeks, the G cambogia group had significantly reduced visceral, subcutaneous, and total fat areas compared with the placebo group (all indices P<0.001). No severe adverse effect was observed at any time in the test period. There were no significant differences in BMI or body weight at week 12, but there were slight numeric decreases in body weight and BMI in men. There were no signs of a rebound effect from week 12 to week 16.
Conclusion: G cambogia reduced abdominal fat accumulation in subjects, regardless of sex, who had the visceral fat accumulation type of obesity. No rebound effect was observed. It is therefore expected that G cambogia may be useful for the prevention and reduction of accumulation of visceral fat.
Keywords: Garcinia cambogia; computed tomography scan; hydroxycitric acid; visceral fat accumulation.
Figures
Similar articles
-
Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.JAMA. 1998 Nov 11;280(18):1596-600. doi: 10.1001/jama.280.18.1596. JAMA. 1998. PMID: 9820262 Clinical Trial.
-
A comprehensive scientific overview of Garcinia cambogia.Fitoterapia. 2015 Apr;102:134-48. doi: 10.1016/j.fitote.2015.02.012. Epub 2015 Feb 27. Fitoterapia. 2015. PMID: 25732350 Review.
-
Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity.Phytother Res. 2008 Sep;22(9):1135-40. doi: 10.1002/ptr.2323. Phytother Res. 2008. PMID: 18729243 Clinical Trial.
-
Effects of Garcinia cambogia extract on serum sex hormones in overweight subjects.Fitoterapia. 2008 Jun;79(4):255-61. doi: 10.1016/j.fitote.2007.12.003. Epub 2008 Feb 9. Fitoterapia. 2008. PMID: 18316163 Clinical Trial.
-
An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management.J Med. 2004;35(1-6):33-48. J Med. 2004. PMID: 18084863 Review.
Cited by
-
Phloroglucinols from the Roots of Garcinia dauphinensis and Their Antiproliferative and Antiplasmodial Activities.J Nat Prod. 2019 Mar 22;82(3):431-439. doi: 10.1021/acs.jnatprod.8b00379. Epub 2018 Oct 24. J Nat Prod. 2019. PMID: 30354100 Free PMC article.
-
Organic Acids from Roselle (Hibiscus sabdariffa L.)-A Brief Review of Its Pharmacological Effects.Biomedicines. 2020 Apr 28;8(5):100. doi: 10.3390/biomedicines8050100. Biomedicines. 2020. PMID: 32354172 Free PMC article. Review.
-
Weight Loss or Liver Loss: A Case Report on Fulminant Hepatic Failure Secondary to Garcinia cambogia Supplementation.Cureus. 2023 Jul 12;15(7):e41778. doi: 10.7759/cureus.41778. eCollection 2023 Jul. Cureus. 2023. PMID: 37575813 Free PMC article.
-
The suppressive effect of Gelidium amansi-EtOH extracts on the adipogenesis with MAPK signals in adipocytes with or without macrophages.Food Sci Biotechnol. 2017 Dec 20;26(6):1715-1723. doi: 10.1007/s10068-017-0230-z. eCollection 2017. Food Sci Biotechnol. 2017. PMID: 30263710 Free PMC article.
-
Anti-Obesity Effects of SPY Fermented with Lactobacillus rhamnosus BST-L.601 via Suppression of Adipogenesis and Lipogenesis in High-Fat Diet-Induced Obese Mice.Foods. 2023 May 30;12(11):2202. doi: 10.3390/foods12112202. Foods. 2023. PMID: 37297447 Free PMC article.
References
-
- The National Nutrition Survey in Japan 2000. Dai-ichi Shuppan Publishing; Tokyo, Japan: 2002. Ministry of Health, Labour and Welfare Japan. 59–60.
-
- Déspres J.P, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: Implications for the prevention of cardiovascular disease. Nutr Res Rev. 1993;6:137–159. - PubMed
-
- Bray G.A. Complications of obesity. Ann Intern Med. 1985;103:1052–1062. - PubMed
-
- Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med. 1985;103:1073–1077. - PubMed
-
- Kissebah A.H, Freedman D.S, Peiris A.N. Health risks of obesity. Med Clin North Am. 1989;73:111–138. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources